Skip to content
Review

Polyendocrine Metabolic Ovarian Syndrome (PMOS; Formerly Polycystic Ovary Syndrome/PCOS) and Susceptibility to Microbial Infections: Mechanisms, Clinical Management, and Reproductive Consequences — A Comprehensive Review

Aug 2026 · Reproductive Sciences · Vol 33, pp. 1816 - 1837 · 0 citations · 170 references
Medicine

TL;DR

Evidence suggests that women with PMOS may be more vulnerable to selected infection-related conditions, especially vaginal dysbiosis, bacterial vaginosis, and vulvovaginal candidiasis, so clinical care should focus on established PMOS management, metabolic optimization, risk-based infection evaluation, and treatment of confirmed infections.

View source

Similar papers

Review Open access Aug 2026

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

Recognizing PMOS as an early-life marker of cardiometabolic disease highlights opportunities for earlier diagnosis, prevention, and individualized risk stratification, supporting integrated, patient-centered care across the life course.

M. Forslund, J. Melin, A. Joham et al. · 0 citations
Review Open access Aug 2026

Polycystic ovarian syndrome: an updated review of pathophysiology, clinical features, biomarkers, and management

Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders affecting women of reproductive age and represents a major global public health challenge. PCOS is a heterogeneous condition characterized by reproductive dysfunction, hyperandrogenism, insulin resistance (IR), and metabolic...

Blessy S. Joseph, D. B, K. Kumar · 0 citations
Review Open access Aug 2026

Polyendocrine Metabolic Ovarian Syndrome: A Brief Review.

Effective PMOS management requires an individualized, multimodal approach that integrates lifestyle medicine with targeted supplementation and pharmacotherapy to address the complex metabolic and reproductive features of the syndrome.

Samia Bennani, Karen Foote · 0 citations
Review Jul 2026

Polycystic ovary syndrome and insulin resistance: A focus on pathogenesis, risk factors, and therapeutic strategies.

A comprehensive and personalized therapeutic approach integrating pharmacological, lifestyle, and microbiome-targeted interventions may significantly improve PCOS management and reduce long-term metabolic and reproductive complications.

J. Singla, Shubhi Yadav, J. Gayen · 0 citations
Review Open access Jan 2026

Gut Microbiome‐Targeted Preventive Strategies for Polyendocrine Metabolic Ovarian Syndrome: Insights From the Prenatal and Early‐Life Environment

It is suggested that prenatal and early postnatal environments shape gut microbiota establishment and maturation, which may interact with multiple developmental pathways and potentially modify susceptibility to PMOS later in life.

A. Kusamoto, Yutaka Osuga, Y. Hirota et al. · 0 citations
Review Open access Sep 2026

The role of intestinal microbial metabolites in polycystic ovary syndrome: mechanistic insights and intervention prospects

Focusing on the gut-ovary axis, this review systematically summarizes the molecular mechanisms by which gut microbial metabolites mediate PCOS-related pathological processes, as well as potential intervention strategies.

Ye Gao, Lin-Lin Fan, Rui Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.